Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
541.08
-1.53 (-0.28%)
At close: Sep 4, 2026, 4:00 PM EDT
541.33
+0.25 (0.05%)
After-hours: Sep 4, 2026, 7:30 PM EDT

Madrigal Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
12,50113,2266,7304,5685,1791,449
Market Cap Growth
28.86%96.52%47.33%-11.79%257.45%-15.74%
Enterprise Value
12,01012,4625,8514,4525,0751,151
Last Close Price
541.08582.34308.57231.38290.2584.74

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-191.16----
PS Ratio
9.7413.8037.36---
PB Ratio
23.8621.958.9211.2726.247.39
P/TBV Ratio
24.2022.228.9811.2726.247.39

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
9.3513.0032.48---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.660.580.160.290.250.00
Net Debt / Equity Ratio
-0.94-1.05-1.07-1.27-1.56-1.37
Net Debt / EBITDA Ratio
1.532.131.621.361.051.11
Net Debt / FCF Ratio
2.383.351.771.591.371.46
Asset Turnover
1.140.830.21---
Inventory Turnover
1.341.03----
Quick Ratio
2.763.605.795.353.103.52
Current Ratio
3.214.016.105.383.123.54
Return on Equity (ROE)
-53.31%-42.49%-80.35%-123.98%-150.12%-110.92%
Return on Assets (ROA)
-17.84%-16.30%-36.98%-47.41%-57.71%-54.09%
Return on Capital Employed (ROCE)
-37.10%-31.60%-57.00%-72.90%-119.00%-123.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-2.60%-2.18%-6.92%-8.18%-5.70%-16.69%
FCF Yield
-1.65%-1.44%-6.79%-7.13%-4.35%-12.71%
Buyback Yield / Dilution
-3.96%-5.46%-13.83%-9.05%-3.64%-7.05%
SEC Filings: 10-K · 10-Q